MedTrace Logo

Trial of Sinphar Lipucan Capsule to Regulate Immune Function

NCT05329675 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2022-11-17

No results posted yet for this study

Summary

Trial of Sinphar Lipucan Capsule to regulate immune function

Conditions

  • Nutrition, Healthy

Interventions

DIETARY_SUPPLEMENT

Sinphar Lipucan Capsule

oral Sinphar Lipucan Capsule 1# (Arm A), 2# (Arm B), or 3# (Arm C)/day for 90 days

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Szu-Yuan Wu · Asia University, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-04-30
Completion
2025-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05329675 on ClinicalTrials.gov